Pharmaceutical Industry The Best Performing Industry,...

One of the most prominent sectors of the market has been healthcare. 2 The healthcare sector makes up 14.0% of the SP 1500 and has had the highest 1 year, 3 year, and 5 year returns at 28.58, 30.51, and 23.85. 1 According the 2014 stock prices, investments within the healthcare sector have outperformed the SP 1500 by 11.9%. The healthcare sector is made up of two industries, health care equipment services group (37% of the healthcare sector) and pharmaceuticals, biotechnology life sciences group (63% of the healthcare sector). According to the SP industry analysis, the biotechnology industry has been the best performing industry, based on stock performance. In each of the last four years the biotechnology industry has outperformed†¦show more content†¦This can be interpreted as, 41.7% of every dollar contributes to net income. Debt to capitalization is used to measure the amount of debt that in the capital structure. Companies with high debt to capitalization show weak fin ancial strength in that more of its operations are financed through debt rather than equity, which increases default risk. The biotechnology industry of the SP 1500 has been constant for the most part, only slightly increasing over the past several years due to mergers and acquisitions. To establish a valuation estimate of the biotechnology industry, the PEG ratio (price to earnings growth ratio) is analyzed. The average PEG ratio for the biotechnology industry is 1.2%, which is just higher than the ideal value representing a fair tradeoff between cost and growth. This means that the industry is slightly overvalued in terms of its growth. According to one year data, today’s market suggest that the overall state of the market is in an upward positive trend. The industries that provided the most potential for profit, revenue, and growth are ideal. Therefore, it is recommended to invest and overweight the biotechnology industry because of its performance and expected growth. Biogen (BIIB) is an SP 500 company that has a 95.12 billion dollar valuation. It is part of the healthcare sector and one of the world’s oldest independent company in the biotechnology industry. Biogen develops, markets andShow MoreRelatedFinancial Analysis of Merck and Pfizer3681 Words   |  15 PagesPharmaceutical Industry The pharmaceutical industry includes companies that research, develop, market or distribute generic and branded drugs. The industry expanded during the 1980’s and drugs to treat heart disease and AIDS were prominent. Consumer demand for nutritional supplements and alternative medicine increased during the 1990’s with the Internet facilitating direct purchases of drugs. Advertising for direct consumption of pharmaceutical drugs became more prominent; pharmaceutical companiesRead MoreIndustry Analysis Using Porters Five Force Model Essay2065 Words   |  9 Pages Industry Analysis Name of the university Name of the student Table of Contents Part 1 3 Industry analysis using Porters Five force Model 3 Finance Industry 3 Healthcare Industry 4 Automobile Industry 4 Consumer Goods Industry 5 Telecom Industry 5 Technology Industry 6 Better performing and less performing industries 6 Profitable industries 7 Recommended industry for team strategy project 7 Part2 8 Underperformance of few companies in consumer goods industry 8 Difference in performanceRead MoreBristol Myers Squibb And Squibb Corporation1966 Words   |  8 Pagesworld’s largest pharmaceutical companies head quartered in New York. BMS has global research facilities and manufacturing plants mainly in the United States and Europe (Hoovers, 2015). The corporation has a unique set of strategic principles that help built the company. The company divested in the nutritional and pharmaceutical divisions. BMS expanded its strategies to become a biopharmaceutical leader. According to Hoovers (2015), the company engaged in the String-of- Pearls pharmaceutical strategy thatRead MoreFinancial Position Of Hikma Pharmaceutical Plc And Glaxosmithkline Plc3479 Words   |  14 Pages Hikma Pharmaceuticals Financial Analysis 22nd Novemeber 2014 Table of Contents Executive Summary 2 1.0: Introduction 3 1.1: Industry overview 3 1.2: Overview Hikma Pharmaceuticals 5 1.3: GlaxoSmithKline overview 7 2.0: Segmentation analysis 8 3.0: Hikma and GlaxoSmithKline financial analysis 10 3.1: Growth Ratios 10 3.2: Profitability Ratios 12 3.3: Efficiency Ratios 13 3.4: Gearing Ratios 15 4.0: Conclusions and recommendations 16 Executive Summary The aim of this reportRead MoreJohnson Johnson6013 Words   |  25 PagesEXECUTIVE SUMMARY Johnson Johnson (JJ), incorporated in 1887, is one of the largest companies in the pharmaceuticals manufacture industry. The company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The company has a well-diversified landscape operating in three major segments: consumer products, pharmaceutical and medical devices and diagnostics. The company s corporate headquarters is located in New Jersey but has facilitiesRead MoreRatio Analysis of 5 Pharmacuticals Companies in Bangladesh3775 Words   |  16 PagesRatio Analysis | 04 | | Categories of Financial Ratios | 04 | | Limitations of Financial Ratios | 08 | Practical Aspects | 01 | ACI Formulations Limited | 10 | | 02 | Beximco Pharmaceuticals LTD. | 11 | | 03 | GlaxoSmithKline Bangladesh Limited | 12 | | 04 | Renata Limited | 13 | | 05 | Square Pharmaceuticals Ltd. | 14 | | Interpretation of Different Ratios | 15 | Conclusion, References, Attachment | 18 | Executive Summary This assignment is a partial requirement of the course ‘SecurityRead MorePre and Post Ma Performance in Accounting Ratio4297 Words   |  18 PagesCHAPTER 1: INTRODUCTION Background of pre and post MA performance in accounting ratio There are loads of tools to measure the performance of a financial performance of an entity but financial ratios is probably the best known tool which is mainly to analyze the performance of an entity by comparing the present to the past relative figures taken or composed from the financial statement . The few categories of ratios are liquidity ratios, profitability ratios, efficiency ratios, debt ratios andRead MoreGroup 4 Final Simulation Report13740 Words   |  55 Pages.................................................................................... 21 3.1 Concept of Growth Stock Value Stock ......................................................................................... 21 3.1.1. Growth Stock ............................................................................................................................ 21 3.1.2. Value Stock ..............................................................................................................Read MoreInvestment Objectives And Beliefs At Investus2362 Words   |  10 Pagescarried out extensive economic research in order to forecast future market conditions. This research is then used in combination with specific stock screens in order to select the best firms to invest in. This report will outline our top-down (macroeconomic analysis) and bottom up (stock screens) research, along with an overview of our risk assessment, performance analysis and portfolio optimization process. Risk Management In order to alleviate risk, we have diversified extensively throughout variousRead MoreEssay on Cambridge Labs Case Analysis5432 Words   |  22 Pagesstrategic objectives based on their mission, vision and core competencies. This framework includes four major aspects, which help firms analyze their current status, the environment, the alternative strategies, and their partner selection. Cambridge Laboratories, an industry-based entrepreneurial firm modeling its strategy based on the industry’s competitiveness, is contemplating a partnership with Canterbury Proteomics Labs, a resource-based firm focusing its strategy based on the value and rarity